WallStreetZenWallStreetZen

NASDAQ: AVDL
Avadel Pharmaceuticals PLC Stock

$16.89+0.05 (+0.3%)
Updated Mar 28, 2024
AVDL Price
$16.89
Fair Value Price
-$0.12
Market Cap
$1.53B
52 Week Low
$8.00
52 Week High
$17.47
P/E
-8.45x
P/B
17.44x
P/S
40.48x
PEG
N/A
Dividend Yield
N/A
Revenue
$27.96M
Earnings
-$160.28M
Gross Margin
97%
Operating Margin
-539.61%
Profit Margin
-573.2%
Debt to Equity
0.88
Operating Cash Flow
-$129M
Beta
0.97
Next Earnings
May 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

AVDL Overview

Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.

Zen Score

Industry Average (26)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how AVDL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

AVDL ($16.89) is overvalued by 13,900.86% relative to our estimate of its Fair Value price of -$0.12 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
AVDL ($16.89) is not significantly undervalued (13,900.86%) relative to our estimate of its Fair Value price of -$0.12 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
AVDL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more AVDL due diligence checks available for Premium users.

Be the first to know about important AVDL news, forecast changes, insider trades & much more!

AVDL News

Valuation

AVDL fair value

Fair Value of AVDL stock based on Discounted Cash Flow (DCF)
Price
$16.89
Fair Value
-$0.12
Undervalued by
13,900.86%
AVDL ($16.89) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
AVDL ($16.89) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
AVDL is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

AVDL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-8.45x
Industry
54.21x
Market
44.51x

AVDL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
17.44x
Industry
2.19x
AVDL is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

AVDL's financial health

Profit margin

Revenue
$19.5M
Net Income
-$28.8M
Profit Margin
-148%
AVDL's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
AVDL's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$164.7M
Liabilities
$77.0M
Debt to equity
0.88
AVDL's short-term assets ($134.20M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
AVDL's short-term assets ($134.20M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
AVDL's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
AVDL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$28.0M
Investing
$27.9M
Financing
-$21.1M
AVDL's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

AVDL vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
AVDL$1.53B+0.30%-8.45x17.44x
TARO$1.59B+0.19%34.70x0.89x
ANIP$1.46B-0.80%80.38x3.37x
DVAX$1.62B0.00%-248.20x2.61x
IRWD$1.36B+1.04%-1.35x-3.94x

Avadel Pharmaceuticals Stock FAQ

What is Avadel Pharmaceuticals's quote symbol?

(NASDAQ: AVDL) Avadel Pharmaceuticals trades on the NASDAQ under the ticker symbol AVDL. Avadel Pharmaceuticals stock quotes can also be displayed as NASDAQ: AVDL.

If you're new to stock investing, here's how to buy Avadel Pharmaceuticals stock.

What is the 52 week high and low for Avadel Pharmaceuticals (NASDAQ: AVDL)?

(NASDAQ: AVDL) Avadel Pharmaceuticals's 52-week high was $17.47, and its 52-week low was $8.00. It is currently -3.32% from its 52-week high and 111.13% from its 52-week low.

How much is Avadel Pharmaceuticals stock worth today?

(NASDAQ: AVDL) Avadel Pharmaceuticals currently has 90,576,998 outstanding shares. With Avadel Pharmaceuticals stock trading at $16.89 per share, the total value of Avadel Pharmaceuticals stock (market capitalization) is $1.53B.

Avadel Pharmaceuticals stock was originally listed at a price of $1.81 in Dec 31, 1997. If you had invested in Avadel Pharmaceuticals stock at $1.81, your return over the last 26 years would have been 831.61%, for an annualized return of 8.96% (not including any dividends or dividend reinvestments).

How much is Avadel Pharmaceuticals's stock price per share?

(NASDAQ: AVDL) Avadel Pharmaceuticals stock price per share is $16.89 today (as of Mar 28, 2024).

What is Avadel Pharmaceuticals's Market Cap?

(NASDAQ: AVDL) Avadel Pharmaceuticals's market cap is $1.53B, as of Mar 29, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Avadel Pharmaceuticals's market cap is calculated by multiplying AVDL's current stock price of $16.89 by AVDL's total outstanding shares of 90,576,998.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.